{"content":"<li class=\"n-box-item date-title\" data-end=\"1480395599\" data-start=\"1480309200\" data-txt=\"Sunday, December 22, 2019\">Monday, November 28, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3227203\" data-ts=\"1480377284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227203-tivoplus-10-ah-on-product-intellectual-property-agreements-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TiVo +10% AH on product, intellectual property agreements with Netflix</a></h4><ul>     <li>TiVo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TIVO\" title=\"TiVo Inc.\">TIVO</a>) <font color=\"green\">+9.8%</font> AH after saying it signed product and intellectual property agreements with Netflix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a>).</li>     <li>TiVo says it will integrate NFLX into its set-top boxes, and include searches across the content catalog and a Netflix button on remote controls; a separate agreement between the two companies gives NFLX a license to TiVo's patent portfolios.</li>     <li>TiVo says the agreements with NFLX do not change FY 2016 estimates the company provided at the time of its Q3 earnings report.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227203\" data-linked=\"TiVo +10% AH on product, intellectual property agreements with Netflix\" data-tweet=\"$TIVO $TIVO $NFLX - TiVo +10% AH on product, intellectual property agreements with Netflix https://seekingalpha.com/news/3227203-tivoplus-10-ah-on-product-intellectual-property-agreements-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3227203-tivoplus-10-ah-on-product-intellectual-property-agreements-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227197\" data-ts=\"1480373340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227197-akorn-prevails-in-durezol-patent-review-first-to-file-status-provides-half-year-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akorn prevails in Durezol patent review; first-to-file status provides half-year market exclusivity after ANDA approved; shares up 2% after hours</a></h4><ul>\n<li>Akorn (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AKRX\" title=\"Akorn, Inc.\">AKRX</a>) perks up <font color=\"green\">2%</font> after hours on light volume in response to its announcement that the U.S. Patent Office's Patent Trial and Appeals Board (PTAB) ruled in its favor in its <em>inter partes</em> review of U.S. Patent No. 6,114,319 covering Alcon's (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) <a href=\"https://www.myalcon.com/products/pharmaceutical/durezol/predict.shtml\" target=\"_blank\">Durezol </a>(difluprednate ophthalmic emulsion).</li>\n<li>The ruling paves the way for full FDA approval of Akorn's Abbreviated New Drug Application (ANDA) for a generic version of the drug. It was the first to file an ANDA so it will have a 180-day period of market exclusivity after approval before other generics can enter the market.</li>\n<li>According to IMS Heath, Durezol sales in the U.S. are ~$190M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227197\" data-linked=\"Akorn prevails in Durezol patent review; first-to-file status provides half-year market exclusivity after ANDA approved; shares up 2% after hours\" data-tweet=\"$AKRX $AKRX $NVS - Akorn prevails in Durezol patent review; first-to-file status provides half-year market exclusivity after ANDA approved; shares up 2% after hours https://seekingalpha.com/news/3227197-akorn-prevails-in-durezol-patent-review-first-to-file-status-provides-half-year-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3227197-akorn-prevails-in-durezol-patent-review-first-to-file-status-provides-half-year-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227194\" data-ts=\"1480372610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227194-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+8.6%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a> <font color='green'>+4.8%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='green'>+4.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> NVLS <font color='red'>-54.4%</font>. <a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a> <font color='red'>-27.6%</font>. <a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='red'>-12.1%</font>. <a href='https://seekingalpha.com/symbol/CUTR' title='Cutera, Inc.'>CUTR</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/BOJA' title='Bojangles&#39;'>BOJA</a> <font color='red'>-4.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227194\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$THO $DNR $CRZO - After Hours Gainers / Losers https://seekingalpha.com/news/3227194-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3227194-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227193\" data-ts=\"1480372244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227193-enrollment-completed-in-jazz-pharmas-late-stage-study-of-jzpminus-110-shares-off-7-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enrollment completed in Jazz Pharma&#39;s late-stage study of JZP-110; shares off 7% after hours</a></h4><ul>\n<li>Jazz Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a>) is down <font color=\"red\">7%</font> after hours on light volume on the heels of the company's announcement that enrollment is now complete in its 240-subject Phase 3 clinical trial assessing JZP-110 for the treatment of excessive sleepiness (ES) associated with narcolepsy. Top-line data are expected in Q2 2017.</li>\n<li>Top-line results in another Phase 3 assessing JZP-110 for the treatment of ES in obstructive sleep apnea should be available in Q1 2017.</li>\n<li>JZP-110 is a selective dopamine and norepinephrine reuptake inhibitor. It has Orphan Drug status in the U.S. for narcolepsy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227193\" data-linked=\"Enrollment completed in Jazz Pharma&#39;s late-stage study of JZP-110; shares off 7% after hours\" data-tweet=\"$JAZZ - Enrollment completed in Jazz Pharma&#39;s late-stage study of JZP-110; shares off 7% after hours https://seekingalpha.com/news/3227193-enrollment-completed-in-jazz-pharmas-late-stage-study-of-jzpminus-110-shares-off-7-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3227193-enrollment-completed-in-jazz-pharmas-late-stage-study-of-jzpminus-110-shares-off-7-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227192\" data-ts=\"1480371544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227192-unitedhealth-higher-on-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UnitedHealth higher on strong guidance</a></h4><ul>\n<li>Ahead of its investor day tomorrow, UnitedHealth says it expects full-year adjusted EPS of $9.30-$9.60 vs. Street estimates of $9.14.</li>\n<li>Cash flow from operations is seen at $11.5B-$12B.</li>\n<li>2016 adjusted EPS of $8 compares to consensus $8.01.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/UNH\" title=\"UnitedHealth Group Inc.\">UNH</a> <font color=\"green\">+2%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227192\" data-linked=\"UnitedHealth higher on strong guidance\" data-tweet=\"$UNH - UnitedHealth higher on strong guidance https://seekingalpha.com/news/3227192-unitedhealth-higher-on-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3227192-unitedhealth-higher-on-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227190\" data-ts=\"1480371340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKE\" target=\"_blank\">CHKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227190-cherokee-to-buy-hi-tec-sports-in-95m-share-purchase-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cherokee to buy Hi-Tec Sports in $95M share purchase deal</a></h4><ul>     <li>Cherokee (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHKE\" title=\"Cherokee Inc.\">CHKE</a>) <font color=\"red\">-2.5%</font> AH after agreeing to acquire footwear company Hi-Tec Sports International for $95.8M in a share purchase agreement.</li>     <li>CHKE expects Hi-Tec to contribute ~$19M of licensing revenues and $7M in adjusted EBITDA during the first full fiscal year after the deal closes.</li>     <li>Announcing preliminary Q3 results, CHKE sees EPS of $0.08 vs. $0.13 analyst consensus estimate on revenues of $6.5M vs $7.8M consensus; for FY 2017, CHKE sees EPS of $0.76 vs. $0.65 consensus on revenues of $32M vs. $33M consensus, which does not any potential impact of the Hi-Tec acquisition.</li>     <li>To help fund the deal, CHKE says it plans to launch a public offering of an unspecified number of common shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227190\" data-linked=\"Cherokee to buy Hi-Tec Sports in $95M share purchase deal\" data-tweet=\"$CHKE $APEX - Cherokee to buy Hi-Tec Sports in $95M share purchase deal https://seekingalpha.com/news/3227190-cherokee-to-buy-hi-tec-sports-in-95m-share-purchase-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3227190-cherokee-to-buy-hi-tec-sports-in-95m-share-purchase-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227189\" data-ts=\"1480370915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALPN\" target=\"_blank\">ALPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227189-nivalis-cystic-fibrosis-candidate-cavosonstat-flunks-mid-stage-study-shares-plummet-55-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nivalis&#39; cystic fibrosis candidate cavosonstat flunks mid-stage study; shares plummet 55% after hours</a></h4><ul>\n<li>Thinly traded nano cap Nivalis Therapeutics (NVLS) craters<font color=\"red\"> 55%</font> after hours on robust volume in response to its announcement of a failed Phase 2 clinical trial assessing cavosonstat in adult cystic fibrosis (CF) patients who have two copies of the <em>F508del-CFTR</em> mutation and were being treated with Vertex Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a>) <a href=\"http://www.orkambi.com/\" target=\"_blank\">ORKAMBI</a> (lumacaftor/ivacaftor).</li>\n<li>Results failed to show a treatment benefit compared to placebo with either a 200 mg or 400 mg dose (twice daily) as measured by percent predicted FEV1, the primary endpoint, or in sweat chloride reduction at week 12, a secondary endpoint.</li>\n<li>CEO Jon Congleton says, \"While we are disappointed in the outcome of this trial, we plan to continue to investigate the therapeutic potential of cavosonstat and our S-nitrosoglutathione reductase (GSNOR) inhibitor portfolio to determine next steps.\"</li>\n<li>Orally administered cavosonstat (N91115) stabilizes the CFTR protein by <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018076/\" target=\"_blank\">inhibiting </a>GSNOR, a potential therapeutic approach to treat asthma as well.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227189\" data-linked=\"Nivalis&#39; cystic fibrosis candidate cavosonstat flunks mid-stage study; shares plummet 55% after hours\" data-tweet=\"$ALPN $ALPN $VRTX - Nivalis&#39; cystic fibrosis candidate cavosonstat flunks mid-stage study; shares plummet 55% after hours https://seekingalpha.com/news/3227189-nivalis-cystic-fibrosis-candidate-cavosonstat-flunks-mid-stage-study-shares-plummet-55-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3227189-nivalis-cystic-fibrosis-candidate-cavosonstat-flunks-mid-stage-study-shares-plummet-55-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227181\" data-ts=\"1480369822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227181-potential-u-s-approval-of-amicus-migalastat-pushed-out-to-least-2020-shares-slump-28-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potential U.S. approval of Amicus&#39; migalastat pushed out to at least 2020; shares slump 28% after hours</a></h4><ul>\n<li>Amicus Therapeutics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FOLD\" title=\"Amicus Therapeutics, Inc.\">FOLD</a>) hopes for accelerated approval in the U.S. of migalastat for the treatment of <a href=\"http://www.fabry.org/fsig.nsf/pdfs/pdfs/%24file/fabry_kidney_prot.pdf\" target=\"_blank\">Fabry disease</a> have vaporized. In a statement released after the close, it says the FDA wants to see more data, specifically a 12-month cross-over study in treatment-naive Fabry patients who have amenable mutation and gastrointestinal (GI) symptoms.</li>\n<li>In addition, the FDA indicated that it does not consider kidney globotriaosylceramide (GL-3) a basis for accelerated approval. GL-3 builds up over time in Fabry patients due to the deficiency of an enzyme called alpha-galactosidase A. Excess GL-3 causes the blood vessels to narrow leading to decreased blood flow and undernourished tissues.</li>\n<li>The company is working with the agency to finalize the study protocol. Enrollment should commence in 2017 with top-line data expected in 2019. A New Drug Application (NDA) will probably not happen until 2020.</li>\n<li>An intermediate Expanded Access Program (EAP) will be set up to ensure short-term access to U.S. Fabry patients who are currently on enzyme replacement therapy and meet EAP guidelines. Clinical trial participants will continue receiving treatment.</li>\n<li>Shares are down <font color=\"red\">28%</font> after hours on robust volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227181\" data-linked=\"Potential U.S. approval of Amicus&#39; migalastat pushed out to at least 2020; shares slump 28% after hours\" data-tweet=\"$FOLD - Potential U.S. approval of Amicus&#39; migalastat pushed out to at least 2020; shares slump 28% after hours https://seekingalpha.com/news/3227181-potential-u-s-approval-of-amicus-migalastat-pushed-out-to-least-2020-shares-slump-28-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3227181-potential-u-s-approval-of-amicus-migalastat-pushed-out-to-least-2020-shares-slump-28-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227173\" data-ts=\"1480368227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCVL\" target=\"_blank\">SCVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227173-weak-guidance-sends-shoe-carnival-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak guidance sends Shoe Carnival lower</a></h4><ul>     <li>Shoe Carnival (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SCVL\" title=\"Shoe Carnival, Inc.\">SCVL</a>) falls flat in late trading after the company's full-year profit guidance disappoints.</li>     <li>The retailer expects FY16 EPS of $1.46-$1.51 vs. $1.58-$1.65 prior and $1.60 consensus.</li>     <li>\"The slow sales of boots and other seasonal merchandise continued through November,\" noted CEO Cliff Sifford.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3227163-shoe-carnival-eps-line-misses-revenue\" target=\"_blank\">Shoe Carnival EPS in-line, misses on revenue</a> (Nov. 28)</li>\n<li>SCVL <font color=\"red\">-6.84%</font> AH to $28.20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227173\" data-linked=\"Weak guidance sends Shoe Carnival lower\" data-tweet=\"$SCVL - Weak guidance sends Shoe Carnival lower https://seekingalpha.com/news/3227173-weak-guidance-sends-shoe-carnival-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3227173-weak-guidance-sends-shoe-carnival-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227165\" data-ts=\"1480367483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCBI\" target=\"_blank\">TCBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227165-texas-capital-bancshares-raising-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Capital Bancshares raising capital</a></h4><ul>\n<li>What a difference a few months make. A $30 stock at the bottom of the oil crash last February, Texas Capital Bancshares (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TCBI\" title=\"Texas Capital Bancshares, Inc.\">TCBI</a>) closed today at $73.15 and is selling 3M shares in a secondary offering. The greenshoe for underwriters JPMorgan, Morgan Stanley, and BAML is for another 450K shares.</li>\n<li>Shares <font color=\"red\">fell 3.1% </font>in today's session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227165\" data-linked=\"Texas Capital Bancshares raising capital\" data-tweet=\"$TCBI - Texas Capital Bancshares raising capital https://seekingalpha.com/news/3227165-texas-capital-bancshares-raising-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3227165-texas-capital-bancshares-raising-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227162\" data-ts=\"1480367240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNET\" target=\"_blank\">VNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227162-21vianet-group-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">21Vianet Group beats by $0.13, beats on revenue</a></h4><ul>\n<li>21Vianet Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VNET\" title=\"21Vianet Group\">VNET</a>): Q3 EPS of -$0.02 <font color=\"green\">beats by $0.13</font>.</li>\n<li>Revenue of $145.2M (-0.1% Y/Y) <font color=\"green\">beats by $8.11M</font>.</li>\n<li>Shares <font color=\"green\">+2.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227162\" data-linked=\"21Vianet Group beats by $0.13, beats on revenue\" data-tweet=\"$VNET - 21Vianet Group beats by $0.13, beats on revenue https://seekingalpha.com/news/3227162-21vianet-group-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3227162-21vianet-group-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227160\" data-ts=\"1480366896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMAX\" target=\"_blank\">IMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227160-imax-slides-on-global-box-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IMAX slides on global box concerns</a></h4><ul>\n<li>IMAX (NYSE:<a href=\"https://seekingalpha.com/symbol/IMAX\" title=\"IMAX Corporation\">IMAX</a>) ended the day down over 7% due to concerns on global box office revenue.</li>\n<li>MKM Partners says IMAX's quarter-to-date global box office revenue is about $131M, a slower pace than what is needed to hit the firm's estimate of $284M for the full three-monthe period.</li>\n<li>MKM still has IMAX rated at Buy with a price target of $40 (+24% upside).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227160\" data-linked=\"IMAX slides on global box concerns\" data-tweet=\"$IMAX - IMAX slides on global box concerns https://seekingalpha.com/news/3227160-imax-slides-on-global-box-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3227160-imax-slides-on-global-box-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227157\" data-ts=\"1480366509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLBS\" target=\"_blank\">GLBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227157-globus-maritime-launches-5m-share-private-placement-25m-share-warrant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globus Maritime launches 5M-share private placement, 25M-share warrant</a></h4><ul>     <li>Globus Maritime (<a href=\"https://seekingalpha.com/symbol/GLBS\" title=\"Globus Maritime Ltd.\">GLBS</a> <font color=\"green\">+2.8%</font>) resumes trading in volatile fashion following a two-hour halt after it announced plans to issue 5M common shares for $5M in gross  proceeds and a warrant to purchase 25M common shares at $1.60/share; shares more then doubled earlier after volatile trading during the prior two weeks.</li>     <li>GLBS says it plans to use the proceeds from the sale for general corporate purposes and working capital including repayment of debt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227157\" data-linked=\"Globus Maritime launches 5M-share private placement, 25M-share warrant\" data-tweet=\"$GLBS - Globus Maritime launches 5M-share private placement, 25M-share warrant https://seekingalpha.com/news/3227157-globus-maritime-launches-5m-share-private-placement-25m-share-warrant?source=tweet\" data-url=\"https://seekingalpha.com/news/3227157-globus-maritime-launches-5m-share-private-placement-25m-share-warrant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227155\" data-ts=\"1480365919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JUNO\" target=\"_blank\">JUNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227155-junos-woes-jcar015-prompts-another-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juno&#39;s woes with JCAR015 prompts another downgrade</a></h4><ul>\n<li>SunTrust Robinson Humphrey downgrades Juno Therapeutics (<a href=\"https://seekingalpha.com/symbol/JUNO\" title=\"Juno Therapeutics\">JUNO</a> <font color=\"red\">-4.3%</font>) to Hold from Buy and lowers the price target to $25 (14% upside) from $48.</li>\n<li>Leerink Swann maintains its Outperform rating but lowers its price target to $34 (55% upside) from $45.  JPMorgan rates the stock a Hold and lowers its price target to $34 from $39.</li>\n<li>Shares tanked last week after a mid-stage study of JCAR015 in a type of leukemia was placed on clinical hold after two patients developed cerebral edema. One died and the other is not expected to recover.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227155\" data-linked=\"Juno&#39;s woes with JCAR015 prompts another downgrade\" data-tweet=\"$JUNO - Juno&#39;s woes with JCAR015 prompts another downgrade https://seekingalpha.com/news/3227155-junos-woes-jcar015-prompts-another-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3227155-junos-woes-jcar015-prompts-another-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227152\" data-ts=\"1480364500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227152-reuters-barrick-reviewing-1_3b-bid-for-kalgoorlie-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Barrick reviewing ~$1.3B bid for Kalgoorlie mine</a></h4><ul>     <li>Barrick Gold (ABX <font color=\"green\">+4.6%</font>) is <a href=\"http://www.reuters.com/article/us-barrick-gold-m-a-australia-idUSKBN13J1VO\" target=\"_blank\">reviewing the financial backing</a> behind a ~$1.3B bid for its 50% stake in Australia's Kalgoorlie mine by China's Minjar Gold, Reuters reports.</li>     <li>It is unclear if Newmont Mining (<a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"green\">+4.7%</font>) - ABX's Kalgoorlie joint venture partner and the mine's operator, and which has said it was interested in buying the remaining stake - is interested in matching Minjar's offer, but the price makes a counteroffer less likely, according to the report.</li>     <li>ABX announced sale plans for Kalgoorlie in July and its president said in September that there was \"robust\" interest in the asset, which analysts had estimated was worth $600M-$1B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227152\" data-linked=\"Reuters: Barrick reviewing ~$1.3B bid for Kalgoorlie mine\" data-tweet=\"$GOLD $GOLD $NEM - Reuters: Barrick reviewing ~$1.3B bid for Kalgoorlie mine https://seekingalpha.com/news/3227152-reuters-barrick-reviewing-1_3b-bid-for-kalgoorlie-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3227152-reuters-barrick-reviewing-1_3b-bid-for-kalgoorlie-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227151\" data-ts=\"1480363984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227151-technology-top-5-gainers-losers-of-3-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:10 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DAIO' title='Data I/O Corporation'>DAIO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CTSH' title='Cognizant Technology Solutions Corporation'>CTSH</a> <font color='green'>+7%</font>. NQ <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/AIRG' title='Airgain'>AIRG</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CYOU' title='Changyou.com Limited'>CYOU</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227151\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:10 pm\" data-tweet=\"$DAIO $I $KEM - Technology - Top 5 Gainers / Losers as of 3:10 pm https://seekingalpha.com/news/3227151-technology-top-5-gainers-losers-of-3-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3227151-technology-top-5-gainers-losers-of-3-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227150\" data-ts=\"1480363702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AETI\" target=\"_blank\">AETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227150-american-electric-technologies-bags-contract-for-landfill-gas-project-sharesplus-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Electric Technologies bags contract for landfill gas project; shares +8%</a></h4><ul>     <li>American Electric Technologies (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AETI\" title=\"American Electric Technologies, Inc.\">AETI</a>) announced that its M&amp;I Electric business has been selected to provide a turnkey power delivery solution for a land fill gas reclamation project in the United States. Terms not disclosed.</li>     <li>M&amp;I will provide a turnkey power delivery solution including a M&amp;I Power Distribution Center with Medium Voltage Switchgear, Medium Voltage Motor Controllers, Low Voltage MCC, transformers and other ancillary power distribution equipment. M&amp;I expects delivery of this project to occur in the Q1'17.</li>     <li>President &amp; CEO Charles Dauber: \u201cWe are pleased to have been selected for this important Land Fill Gas project with a leading international independent provider of comprehensive energy efficiency and renewable energy solutions. This project exemplifies our mission of Empowering EnergyTM and continues to show our progress in delivering customized, turnkey solutions for challenging energy industry project.\u201d</li>\n<li>Shares<font color=\"green\"> +8%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227150\" data-linked=\"American Electric Technologies bags contract for landfill gas project; shares +8%\" data-tweet=\"$AETI $SLNG - American Electric Technologies bags contract for landfill gas project; shares +8% https://seekingalpha.com/news/3227150-american-electric-technologies-bags-contract-for-landfill-gas-project-sharesplus-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3227150-american-electric-technologies-bags-contract-for-landfill-gas-project-sharesplus-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227148\" data-ts=\"1480362703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPX\" target=\"_blank\">WPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227148-wpx-energy-callon-petroleum-rated-buy-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPX Energy, Callon Petroleum rated Buy at Deutsche Bank</a></h4><ul>     <li>WPX Energy (<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"red\">-2.9%</font>) and Callon Petroleum (<a href=\"https://seekingalpha.com/symbol/CPE\" title=\"Callon Petroleum Co.\">CPE</a> <font color=\"red\">-5.4%</font>) are awarded Buy ratings at Deutsche Bank on valuation, margin improvement and exposure to emerging core areas.</li>     <li>Deutsche Bank <a href=\"http://www.streetinsider.com/Upgrades/Deutsche+Bank+Upgrades+WPX+Energy+%28WPX%29+to+Buy/12285296.html\" target=\"_blank\">upgrades WPX to Buy</a> from Hold and raises its price target to $17 from $15, seeing producers with the combination of Midland growth and Delaware positive rate of change as holding the best differentiated outlook for 2017.</li>     <li>The firm <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Starts+Callon+Petroleum+%28CPE%29+at+Buy/12285290.html\" target=\"_blank\">initiates CPE with a Buy rating</a> and $19 price target, citing CPE's core economics, capital efficiency and inventory catalysts; using its core Midland assets as a launching pad for expansion, CPE has aggressively acquired inventory and resource potential,  benefiting from first-mover advantages while improving its runway for growth, the firm says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227148\" data-linked=\"WPX Energy, Callon Petroleum rated Buy at Deutsche Bank\" data-tweet=\"$WPX $WPX $CPE - WPX Energy, Callon Petroleum rated Buy at Deutsche Bank https://seekingalpha.com/news/3227148-wpx-energy-callon-petroleum-rated-buy-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3227148-wpx-energy-callon-petroleum-rated-buy-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227141\" data-ts=\"1480360346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227141-energy-materials-top-5-gainers-losers-of-2-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm</a></h4><ul>     <li><b>Gainers:</b> MPET <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MEP' title='Midcoast Energy Partners, LP'>MEP</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227141\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm\" data-tweet=\"$TELL $PQ $HNR - Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm https://seekingalpha.com/news/3227141-energy-materials-top-5-gainers-losers-of-2-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3227141-energy-materials-top-5-gainers-losers-of-2-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227132\" data-ts=\"1480358495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLRE\" target=\"_blank\">GLRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227132-einhorn-fan-of-bayer-without-monsanto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Einhorn a fan of Bayer with or without Monsanto</a></h4><ul>\n<li>Presenting at the Robin Hood Investors Conference, Greenlight Capital's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GLRE\" title=\"Greenlight Capital Re, Ltd.\">GLRE</a>) David Einhorn tells the crowd he likes Bayer (<a href=\"https://seekingalpha.com/symbol/BAYRY\" title=\"Bayer A.G. ADR\">OTCPK:BAYRY</a>) as a standalone or after a merger with Monsanto (NYSE:<a href=\"https://seekingalpha.com/symbol/MON\" title=\"Monsanto Company\">MON</a>).</li>\n<li>Both stocks are modestly lower on the session, but have perked up since Einhorn made his comments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227132\" data-linked=\"Einhorn a fan of Bayer with or without Monsanto\" data-tweet=\"$GLRE $GLRE $BAYRY - Einhorn a fan of Bayer with or without Monsanto https://seekingalpha.com/news/3227132-einhorn-fan-of-bayer-without-monsanto?source=tweet\" data-url=\"https://seekingalpha.com/news/3227132-einhorn-fan-of-bayer-without-monsanto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227130\" data-ts=\"1480357940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227130-under-armour-class-c-shares-surge-on-ticker-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour Class C shares surge on ticker change</a></h4><ul>\n<li>The objective <a href=\"https://seekingalpha.com/news/3227031-symbol-changes-coming-armour\" target=\"_blank\">behind the renaming</a> - Under Armour Class A stock (NYSE:<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a>) to \"UAA\" and Class C stock (UA.C) to \"UA\" - is to drive the two share class prices toward parity, <a href=\"http://www.cnbc.com/2016/11/28/under-armour-class-c-shares-up-more-than-8-percent-after-ticker-change-announcement.html?__source=twitter\" target=\"_blank\">says Stifel's Jim Duffy</a>.</li>\n<li>Since their creation in April, the Class C shares - which are used for employee compensation and don't have voting rights - have underperformed, says Duffy.</li>\n<li>UA today is<font color=\"green\"> higher by 2.95% </font>to $31.50, and UA.C is <font color=\"green\">up 9.4%</font> to $26.41.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227130\" data-linked=\"Under Armour Class C shares surge on ticker change\" data-tweet=\"$UAA $UAA $UA - Under Armour Class C shares surge on ticker change https://seekingalpha.com/news/3227130-under-armour-class-c-shares-surge-on-ticker-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3227130-under-armour-class-c-shares-surge-on-ticker-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227128\" data-ts=\"1480357187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227128-new-leg-up-for-time-on-bloomberg-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New leg up for Time on Bloomberg report</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/news/3226990-time-inc-reportedly-turns-buyout-offer\" target=\"_blank\">An earlier story</a> from the <em>NYPost</em> suggested Edgar Bronfman teamed up with Ynon Kreiz to offer $18 per share for Time Inc. (TIME).</li>\n<li>Having reviewed the letter from the Bronfman/Kreiz to the Time board, Bloomberg says the all-cash proposal is for $18-$20.</li>\n<li>Shares <font color=\"green\">+20.9%</font> to $16.45.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227128\" data-linked=\"New leg up for Time on Bloomberg report\" data-tweet=\"$MDP - New leg up for Time on Bloomberg report https://seekingalpha.com/news/3227128-new-leg-up-for-time-on-bloomberg-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3227128-new-leg-up-for-time-on-bloomberg-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227127\" data-ts=\"1480357056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSH\" target=\"_blank\">CTSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227127-william-blair-restates-cognizant-market-perform-subsequent-elliot-management-address\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Blair restates Cognizant at Market Perform subsequent Elliot Management address</a></h4><ul>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2016/11/28/cognizant-surges-8-elliotts-plan-a-bulls-eye-says-william-blair/\" target=\"_blank\">Analyst Anil Doradla</a> notes Elliot Management's points are consistent with investor demands of Cognizant (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTSH\" title=\"Cognizant Technology Solutions Corporation\">CTSH</a>) and his firm's <a href=\"https://seekingalpha.com/news/3226680-cognizant-technology-solutions-downgraded-market-perform-william-blair\" target=\"_blank\">downgrade</a> on shares of the company last week.</li>\n<li>Nonetheless, despite the resulting <font color=\"green\">7%+</font> gains on today's session and value-enhancing intentions, Doradla suggests substantial work is required to achieve stated goals and consequently remains unmoved on rating due to expected volatility on awaited clarity of longer-term strategy.</li>\n<li>Earlier \u2013 <a href=\"https://seekingalpha.com/news/3227018-cognizant-technology-solutions-plus-8_7-percent-pre-market-elliot-management-outlines\" target=\"_blank\">Cognizant Technology Solutions +8.7% pre-market, Elliot Management outlines enhancement plan in letter to board</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227127\" data-linked=\"William Blair restates Cognizant at Market Perform subsequent Elliot Management address\" data-tweet=\"$CTSH - William Blair restates Cognizant at Market Perform subsequent Elliot Management address https://seekingalpha.com/news/3227127-william-blair-restates-cognizant-market-perform-subsequent-elliot-management-address?source=tweet\" data-url=\"https://seekingalpha.com/news/3227127-william-blair-restates-cognizant-market-perform-subsequent-elliot-management-address\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227204\" data-ts=\"1480356904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRO\" target=\"_blank\">MRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227204-marathon-oil-started-buy-r-f-laffert\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Oil started at Buy at R.F. Laffert</a></h4><ul>     <li>Marathon Oil (<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a> <font color=\"red\">-1.8%</font>) is initiated with a <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/11/28/marathon-oil-location-location-location/\" target=\"_blank\">Buy rating</a> and a $29 price target at R.F. Laffert, citing valuation, a solid balance sheet, and upside potential to reserves and net asset value via its position in the STACK/SCOOP play.</li>     <li>The firm says MRO owns a strong set of core producing oil and gas assets that have proved to be resilient in a weak commodity environment.</li>     <li>As of the H2 2016, MRO\u2019s Oklahoma assets represented 2.2B boe of 2P resources and 3.4B boe in total resources, part of which will end up as proved reserves and likely providing upside for the shares, the firm says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227204\" data-linked=\"Marathon Oil started at Buy at R.F. Laffert\" data-tweet=\"$MRO - Marathon Oil started at Buy at R.F. Laffert https://seekingalpha.com/news/3227204-marathon-oil-started-buy-r-f-laffert?source=tweet\" data-url=\"https://seekingalpha.com/news/3227204-marathon-oil-started-buy-r-f-laffert\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227122\" data-ts=\"1480356044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227122-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TRC' title='Tejon Ranch Co.'>TRC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/HNNA' title='Hennessy Advisors, Inc.'>HNNA</a> <font color='red'>-6%</font>. WAC <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3227122\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MBI $TRC $HNNA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3227122-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3227122-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227119\" data-ts=\"1480355528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227119-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/PZRX\" title=\"PhaseRx\">PZRX</a> <font color=\"green\">+145%</font>. <a href=\"https://seekingalpha.com/symbol/GLBS\" title=\"Globus Maritime Ltd.\">GLBS</a> <font color=\"green\">+103%</font>. <a href=\"https://seekingalpha.com/symbol/REPH\" title=\"Recro Pharma Inc\">REPH</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/AIRI\" title=\"Air Industries Group, Inc.\">AIRI</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/NVFY\" title=\"Nova Lifestyle, Inc.\">NVFY</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/HTBX\" title=\"Heat Biologics, Inc.\">HTBX</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CFRX\" title=\"ContraFect Corp.\">CFRX</a> <font color=\"green\">+17%</font>. TIME <font color=\"green\">+16%</font>. MPET <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AHPI\" title=\"Allied Healthcare Products, Inc.\">AHPI</a> <font color=\"green\">+15%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/AIRG\" title=\"Airgain\">AIRG</a> <font color=\"red\">-20%</font>. SKLN <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/OPHT\" title=\"Ophthotech Corporation\">OPHT</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/DELT\" title=\"Delta Technology Holdings Limited\">DELT</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CGIX\" title=\"Cancer Genetics, Inc.\">CGIX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/BOSC\" title=\"B.O.S. Better Online Solutions\">BOSC</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/CRC\" title=\"California Resources Corporation\">CRC</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/RFIL\" title=\"RF Industries, Ltd.\">RFIL</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/STRP\" title=\"Straight Path Communications Inc.\">STRP</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227119\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PZRX $GLBS $REPH - Midday Gainers / Losers https://seekingalpha.com/news/3227119-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3227119-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227115\" data-ts=\"1480354296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227115-deere-ag-equipment-stocks-upgraded-piper-jaffray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere, other ag equipment stocks upgraded at Piper jaffray</a></h4><ul>     <li>Piper Jaffray <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/11/28/deere-a-bummer-of-an-upgrade/\" target=\"_blank\">upgrades</a> Deere (<a href=\"https://seekingalpha.com/symbol/DE\" title=\"Deere &amp; Company\">DE</a> <font color=\"red\">-1.5%</font>) and five other agricultural equipment companies, saying it believes investors will continue to pay lofty multiples, given that the bottom of the cycle is close at hand, and valuations simply will be pushed out another year if the downturn persists as expected.</li>     <li>In addition to DE, Jaffray upgrades AGCO (<a href=\"https://seekingalpha.com/symbol/AGCO\" title=\"AGCO Corporation\">AGCO</a> <font color=\"red\">-0.2%</font>), American Vanguard (<a href=\"https://seekingalpha.com/symbol/AVD\" title=\"American Vanguard Corporation\">AVD</a> <font color=\"green\">+2.5%</font>), FMC Corp. (<a href=\"https://seekingalpha.com/symbol/FMC\" title=\"FMC Corporation\">FMC</a> <font color=\"green\">+0.4%</font>), Lindsay (<a href=\"https://seekingalpha.com/symbol/LNN\" title=\"Lindsay Corporation\">LNN</a> <font color=\"green\">+2.6%</font>) and CNH Industrial (<a href=\"https://seekingalpha.com/symbol/CNHI\" title=\"CNH Industrial N.V.\">CNHI</a> <font color=\"red\">-1.5%</font>) to Neutral from Underweight</li>     <li>Jaffray says DE's FY 2017 guidance that <a href=\"https://seekingalpha.com/news/3226768-deere-cruises-record-highs-earnings-rout-expectations\" target=\"_blank\">far exceeded expectations</a> is providing the market with expectations that the cycle is nearing the bottom and poised for a recovery in the near term, and the firm continues to expect that ag will be challenging but now thinks its previous expectation to see pressure on valuations is unlikely.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227115\" data-linked=\"Deere, other ag equipment stocks upgraded at Piper jaffray\" data-tweet=\"$DE $DE $AGCO - Deere, other ag equipment stocks upgraded at Piper jaffray https://seekingalpha.com/news/3227115-deere-ag-equipment-stocks-upgraded-piper-jaffray?source=tweet\" data-url=\"https://seekingalpha.com/news/3227115-deere-ag-equipment-stocks-upgraded-piper-jaffray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227113\" data-ts=\"1480354016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227113-oil-reverses-early-losses-turns-sharply-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil reverses early losses, turns sharply higher</a></h4><ul>\n<li>Oil and the stocks of European oil players were hit early today, with <a href=\"http://www.wsj.com/articles/saudi-arabia-to-skip-meeting-with-non-opec-producers-1480097402\" target=\"_blank\">a weekend story about</a> Saudi Arabian oil honchos pulling out of a Monday meeting with their Russian counterparts setting the opening tone.</li>\n<li>Later in the session though, Iraqi Oil Minister Jabbar al-Luaibi said he was optimistic a production deal will be reached later this week.</li>\n<li>WTI crude is now <font color=\"green\">higher by 2.55%</font> on the session to $47.24 per barrel. <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"green\">+1.95%</font>\n</li>\n<li>The <a href=\"https://seekingalpha.com/symbol/XLE\" title=\"Energy Select Sector SPDR ETF\">XLE</a>, however, remains in the<font color=\"red\"> red by 0.45%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILK\" title=\"ProShares K-1 Free Crude Oil Strategy ETF\">OILK</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227113\" data-linked=\"Oil reverses early losses, turns sharply higher\" data-tweet=\"$USO $XLE $OIL - Oil reverses early losses, turns sharply higher https://seekingalpha.com/news/3227113-oil-reverses-early-losses-turns-sharply-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3227113-oil-reverses-early-losses-turns-sharply-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227104\" data-ts=\"1480352905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOSL\" target=\"_blank\">AOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227104-small-cap-stocks-hitting-52-week-highs-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small-cap stocks hitting 52-week highs/lows</a></h4><ul><li>Small-cap names making 52-week highs today on double the normal volume:</li><li>Alpha &amp; Omega Semi (<a href='https://seekingalpha.com/symbol/AOSL' title='Alpha and Omega Semiconductor Limited'>AOSL</a> <font color='green'>+3.1%</font>)</li><li>Antares Pharma (<a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+2%</font>)</li><li>Bel Fuse (<a href='https://seekingalpha.com/symbol/BELFA' title='Bel Fuse Inc.'>BELFA</a> <font color='red'>-1.1%</font>)</li><li>Bojangles (<a href='https://seekingalpha.com/symbol/BOJA' title='Bojangles&#39;'>BOJA</a> <font color='red'>-1.5%</font>)</li><li>Lindsay Corp. (<a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a> <font color='green'>+2.9%</font>)</li><li>MBIA (<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='green'>+8.2%</font>)</li><li>PennyMac Financial (<a href='https://seekingalpha.com/symbol/PFSI' title='PennyMac Financial Services'>PFSI</a> <font color='green'>+2.5%</font>)</li><li>TICC Capital (TICC <font color='red'>-0.3%</font>)</li><li>World Point Terminals (<a href='https://seekingalpha.com/symbol/WPT' title='World Point Terminals, LP'>WPT</a> <font color='green'>+1.1%</font>)</li><li>New 52-week lows on any volume:</li><li>Ferreligas Partners (<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a> <font color='red'>-6.9%</font>)</li><li>iKang Healthcare (<a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a> <font color='red'>-9.6%</font>)</li><li>Novadaq Technologies (<a href='https://seekingalpha.com/symbol/NVDQ' title='Novadaq Technologies Inc.'>NVDQ</a> <font color='red'>-5%</font>)</li><li>PDL BioPharma (<a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a> <font color='red'>-3.5%</font>)</li><li>Petrobas Argentina (<a href='https://seekingalpha.com/symbol/PZE' title='Petrobras Argentina S.A.'>PZE</a> <font color='red'>-3.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3227104\" data-linked=\"Small-cap stocks hitting 52-week highs/lows\" data-tweet=\"$AOSL $AOSL $ATRS - Small-cap stocks hitting 52-week highs/lows https://seekingalpha.com/news/3227104-small-cap-stocks-hitting-52-week-highs-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3227104-small-cap-stocks-hitting-52-week-highs-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227100\" data-ts=\"1480352670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227100-large-and-mid-cap-names-making-52-week-highs-lows-on-strong-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Large- and mid-cap names making 52 week highs/lows on strong volume</a></h4><ul>\n<li>Hitting fresh 52-week highs on double the normal volume today:</li>\n<li>Vale (<a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"green\">+5.2%</font>)</li>\n<li>Cliff's Natural Resource (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-1.8%</font>)</li>\n<li>Essent Group (<a href=\"https://seekingalpha.com/symbol/ESNT\" title=\"Essent Group Ltd.\">ESNT</a> <font color=\"green\">+1.8%</font>)</li>\n<li>Finisar (<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+4.7%</font>)</li>\n<li>China Lodging (<a href=\"https://seekingalpha.com/symbol/HTHT\" title=\"Huazhu Group Limited ADR\">HTHT</a> <font color=\"green\">+5.8%</font>)</li>\n<li>51job (<a href=\"https://seekingalpha.com/symbol/JOBS\" title=\"51job, Inc.\">JOBS</a> <font color=\"green\">+1.4%</font>)</li>\n<li>PrivateBancorp (<a href=\"https://seekingalpha.com/symbol/PVTB\" title=\"PrivateBancorp, Inc.\">PVTB</a> <font color=\"green\">+0.1%</font>)</li>\n<li>Alleghany Corp. (<a href=\"https://seekingalpha.com/symbol/Y\" title=\"Alleghany Corporation\">Y</a> <font color=\"red\">-0.1%</font>)</li>\n<li>The only fresh 52-week lows today are in European telecom:</li>\n<li>Vodafone (<a href=\"https://seekingalpha.com/symbol/VOD\" title=\"Vodafone Group Plc\">VOD</a> <font color=\"red\">-2.3%</font>)</li>\n<li>Orange (<a href=\"https://seekingalpha.com/symbol/ORAN\" title=\"Orange\">ORAN</a> <font color=\"red\">-1.4%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227100\" data-linked=\"Large- and mid-cap names making 52 week highs/lows on strong volume\" data-tweet=\"$VALE $VALE $CLF - Large- and mid-cap names making 52 week highs/lows on strong volume https://seekingalpha.com/news/3227100-large-and-mid-cap-names-making-52-week-highs-lows-on-strong-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3227100-large-and-mid-cap-names-making-52-week-highs-lows-on-strong-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227095\" data-ts=\"1480352447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227095-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/NVFY\" title=\"Nova Lifestyle, Inc.\">NVFY</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/CAAS\" title=\"China Automotive Systems, Inc.\">CAAS</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/KNDI\" title=\"Kandi Technologies Group, Inc.\">KNDI</a> <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SORL\" title=\"SORL Auto Parts, Inc.\">SORL</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/RFP\" title=\"Resolute Forest Products, Inc.\">RFP</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/ABAC-OLD\" title=\"Renmin Tianli Group\">ABAC-OLD</a> <font color=\"red\">-7%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227095\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NVFY $CAAS $KNDI - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3227095-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3227095-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227088\" data-ts=\"1480351288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRI\" target=\"_blank\">DRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227088-maxim-sees-valuation-played-out-on-darden-and-cracker-barrel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim sees valuation played out on Darden and Cracker Barrel</a></h4><ul> <li>Maxim turns cautious on Darden Restaurants (<a href='https://seekingalpha.com/symbol/DRI' title='Darden Restaurants, Inc.'>DRI</a> <font color='red'>-1.3%</font>) after shares rose 20% in less than two months. Shares are rated at Neutral.</li><li>The long-term view on the restaurant operator from Maxim is still positive with Darden building new high-end restaurants and the labor regulatory environment expected to ease.</li> <li>The investment firm also shifts to Neutral on Cracker Barrel (<a href='https://seekingalpha.com/symbol/CBRL' title='Cracker Barrel Old Country Store, Inc.'>CBRL</a> <font color='red'>-1.5%</font>) on a similar outlook. Shares of CBRL are up 18% since the U.S. election.</li> <li>Source: Bloomberg</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3227088\" data-linked=\"Maxim sees valuation played out on Darden and Cracker Barrel\" data-tweet=\"$DRI $DRI $CBRL - Maxim sees valuation played out on Darden and Cracker Barrel https://seekingalpha.com/news/3227088-maxim-sees-valuation-played-out-on-darden-and-cracker-barrel?source=tweet\" data-url=\"https://seekingalpha.com/news/3227088-maxim-sees-valuation-played-out-on-darden-and-cracker-barrel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227083\" data-ts=\"1480350998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZRX\" target=\"_blank\">PZRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227083-phaserx-lead-product-candidate-orphan-drug-for-rare-enzyme-deficiency-shares-rocket-92\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PhaseRx lead product candidate an Orphan Drug for rare enzyme deficiency; shares rocket 92%</a></h4><ul>\n<li>Investors in thinly traded nano cap PhaseRx (<a href=\"https://seekingalpha.com/symbol/PZRX\" title=\"PhaseRx\">PZRX</a> <font color=\"green\">+92.1%</font>) didn't need much news to hit the buy button. Shares are up on a whopping 268x surge volume on the company's announcement that lead product candidate PRX-OTC has been designated an Orphan Drug in the U.S. for the treatment of <a href=\"https://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency\" target=\"_blank\">ornithine transcarbamylase deficiency</a>, a rare genetic disorder that causes ammonia to accumulate in the body.</li>\n<li>PRX-OTC is an intracellular enzyme replacement therapy designed to replace the defective or missing ornithine transcarbamylase.</li>\n<li>\n<a href=\"http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/ucm135122.htm\" target=\"_blank\">Orphan Drug status</a> provides for an additional seven-year period of market exclusivity, if approved. The FDA grants the status based on an application submitted by the company that explains the rare disease and the rationale for using the drug to treat it. All the clinical development work and regulatory application and review still needs to be done. PRX-OTC is not even in Phase 1 yet.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227083\" data-linked=\"PhaseRx lead product candidate an Orphan Drug for rare enzyme deficiency; shares rocket 92%\" data-tweet=\"$PZRX - PhaseRx lead product candidate an Orphan Drug for rare enzyme deficiency; shares rocket 92% https://seekingalpha.com/news/3227083-phaserx-lead-product-candidate-orphan-drug-for-rare-enzyme-deficiency-shares-rocket-92?source=tweet\" data-url=\"https://seekingalpha.com/news/3227083-phaserx-lead-product-candidate-orphan-drug-for-rare-enzyme-deficiency-shares-rocket-92\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227085\" data-ts=\"1480350708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227085-boxplus-2_5-potential-for-sector-consolidation-considered-drexel-hamilton-reiterates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box +2.5%; potential for sector consolidation considered, Drexel Hamilton reiterates positively</a></h4><ul>\n<li>\n<a href=\"http://www.crn.com/news/storage/300082883/cloud-storage-enterprise-file-sync-and-share-business-grows-but-consolidation-may-be-ahead.htm/pgno/0/2\" target=\"_blank\">Supposition</a> Box (NYSE:<a href=\"https://seekingalpha.com/symbol/BOX\" title=\"Box\">BOX</a>) could eventually become a takeover target by Microsoft is issued today by Rafi Kronzon, CEO of New York-based technology services and support firm <a href=\"http://cartwheelit.com/\" target=\"_blank\">Cartwheel</a>, noting, \"Microsoft is letting Box come into the Office 365 space. I suspect Microsoft will someday acquire Box or Dropbox.\"</li>\n<li>Also this morning, Drexel Hamilton's Brian White <a href=\"http://www.streetinsider.com/Analyst+Comments/Drexel+Hamilton+Remains+Bullish+on+Box+%28BOX%29+Ahead+of+3Q/12285756.html\" target=\"_blank\">restates</a> a Buy position and $18 target (current price $15.72) on Box ahead of Q3 earnings expected Wednesday. Firm estimates revenue at $100.7M and loss per share at $0.19.</li>\n<li>Box shares to $15.72.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227085\" data-linked=\"Box +2.5%; potential for sector consolidation considered, Drexel Hamilton reiterates positively\" data-tweet=\"$BOX $DBX - Box +2.5%; potential for sector consolidation considered, Drexel Hamilton reiterates positively https://seekingalpha.com/news/3227085-boxplus-2_5-potential-for-sector-consolidation-considered-drexel-hamilton-reiterates?source=tweet\" data-url=\"https://seekingalpha.com/news/3227085-boxplus-2_5-potential-for-sector-consolidation-considered-drexel-hamilton-reiterates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227082\" data-ts=\"1480350131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWN\" target=\"_blank\">SWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227082-southwestern-energy-surges-on-bmo-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwestern Energy surges on BMO upgrade</a></h4><ul>     <li>Southwestern Energy (<a href=\"https://seekingalpha.com/symbol/SWN\" title=\"Southwestern Energy Co.\">SWN</a> <font color=\"green\">+3.4%</font>) shoots higher after BMO Capital <a href=\"http://www.cnbc.com/2016/11/28/southwestern-energy-pops-as-bmo-sees-the-driller-outperforming-peers.html\" target=\"_blank\">upgrades</a> shares to Outperform from Market Perform with an $18 price target, based on valuation compared with other natural gas-focused drillers and the fundamental strength of the company's near-term business prospects.</li>     <li>BMO says it sees SWN as affording relatively inexpensively priced exposure to natural gas, backed by a strong balance sheet thanks in part to proceeds from asset sales and equity raises.</li>     <li>BMO believes SWN is generating some of the best debt-adjusted production and cash flow growth in the group, which contributes to improved corporate-level returns and a stronger balance sheet.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227082\" data-linked=\"Southwestern Energy surges on BMO upgrade\" data-tweet=\"$SWN - Southwestern Energy surges on BMO upgrade https://seekingalpha.com/news/3227082-southwestern-energy-surges-on-bmo-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3227082-southwestern-energy-surges-on-bmo-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227075\" data-ts=\"1480349111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVFY\" target=\"_blank\">NVFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227075-nova-lifestyle-soars-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nova Lifestyle soars on heavy volume</a></h4><ul> <li>Nova Lifestyle (<a href=\"https://seekingalpha.com/symbol/NVFY\" title=\"Nova Lifestyle, Inc.\">NVFY</a> <font color=\"green\">+23.5%</font>) pops on what some traders are calling a short squeeze.</li>\n<li>Volume on Nova is already 2X normal activity.</li> <li>The company's CEO <a href=\"http://www.novalifestyle.com/data/uploads/20161010-Nova-LifeStyle-NVFYCEOchangePRFINAL.pdf\" target=\"_blank\">resigned</a> last month.</li>\n<li><a href=\"http://www.nasdaq.com/symbol/nvfy/short-interest\" target=\"_blank\">Nasdaq short interest report on NOVA</a></li>   </ul><div class=\"tiny-share-widget\" data-id=\"3227075\" data-linked=\"Nova Lifestyle soars on heavy volume\" data-tweet=\"$NVFY - Nova Lifestyle soars on heavy volume https://seekingalpha.com/news/3227075-nova-lifestyle-soars-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3227075-nova-lifestyle-soars-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227072\" data-ts=\"1480348830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227072-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/PZRX\" title=\"PhaseRx\">PZRX</a> <font color=\"green\">+112%</font>. <a href=\"https://seekingalpha.com/symbol/HTBX\" title=\"Heat Biologics, Inc.\">HTBX</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/REPH\" title=\"Recro Pharma Inc\">REPH</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AHPI\" title=\"Allied Healthcare Products, Inc.\">AHPI</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a> <font color=\"green\">+16%</font>.</li>\n<li>\n<b>Losers:</b> SKLN <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/MYOV\" title=\"Myovant Sciences\">MYOV</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/NURO\" title=\"NeuroMetrix, Inc.\">NURO</a> <font color=\"red\">-9%</font>. RXII <font color=\"red\">-9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227072\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PZRX $HTBX $REPH - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3227072-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3227072-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227074\" data-ts=\"1480348783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227074-teck-resources-gets-analyst-stock-price-hike-from-met-coal-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources gets analyst stock price hike from met coal rally</a></h4><ul>     <li>Higher metallurgical coal prices prompt CIBC World Markets to <a href=\"http://business.financialpost.com/investing/trading-desk/teck-resources-ltd-gets-lift-from-met-coal-rally\" target=\"_blank\">raise its stock price target</a> for Teck Resources (TCK <font color=\"green\">+2.7%</font>) to C$44 from C$33 while maintaining a Sector Outperform rating, and lift its 2017 cash flow per share forecast for TCK to $8.76 from $5.44.</li>     <li>TCK last week updated its Q4 realized price expectations for all steelmaking coal productsl, raising its outlook to US$200-$205/metric ton from earlier guidance of ~US$185/ton.</li>     <li>CIBC believe the revision is consistent with the  application of historical quality-related price spreads, and that it looks appropriate given TCK\u2019s sale mix of  60% contract and 40% market-related prices.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227074\" data-linked=\"Teck Resources gets analyst stock price hike from met coal rally\" data-tweet=\"$TECK - Teck Resources gets analyst stock price hike from met coal rally https://seekingalpha.com/news/3227074-teck-resources-gets-analyst-stock-price-hike-from-met-coal-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3227074-teck-resources-gets-analyst-stock-price-hike-from-met-coal-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227068\" data-ts=\"1480347939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227068-bank-insiders-cash-in-amid-post-election-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank insiders cash in amid post-election rally</a></h4><ul>\n<li>A full 39% of the 132 banks in its coverage universe saw some insider selling between Nov. 9 and Nov. 18, says Raymond James, noting an even mix of large regional and smaller lenders.</li>\n<li>Of the 51 banks with insider sales, 39 had sales exceeding $250K.</li>\n<li>Source: Bloomberg</li>\n<li>Banks this morning are taking a breather from their rally: <a href=\"https://seekingalpha.com/symbol/KBE\" title=\"SPDR S&amp;P Bank ETF\">KBE</a> <font color=\"red\">-0.95%</font>, <a href=\"https://seekingalpha.com/symbol/KRE\" title=\"SPDR S&amp;P Regional Banking ETF\">KRE</a> <font color=\"red\">-1%</font>.</li>\n<li>The <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a> is <font color=\"red\">down 0.7%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a>, <a href=\"https://seekingalpha.com/symbol/FAS\" title=\"Direxion Daily Financial Bull 3x Shares ETF\">FAS</a>, <a href=\"https://seekingalpha.com/symbol/FAZ\" title=\"Direxion Daily Financial Bear 3x Shares ETF\">FAZ</a>, <a href=\"https://seekingalpha.com/symbol/KRE\" title=\"SPDR S&amp;P Regional Banking ETF\">KRE</a>, <a href=\"https://seekingalpha.com/symbol/UYG\" title=\"ProShares Ultra Financials ETF\">UYG</a>, <a href=\"https://seekingalpha.com/symbol/VFH\" title=\"Vanguard Financials ETF\">VFH</a>, <a href=\"https://seekingalpha.com/symbol/KBE\" title=\"SPDR S&amp;P Bank ETF\">KBE</a>, <a href=\"https://seekingalpha.com/symbol/IYF\" title=\"iShares U.S. Financials ETF\">IYF</a>, <a href=\"https://seekingalpha.com/symbol/BTO\" title=\"John Hancock Financial Opportunity Fund\">BTO</a>, <a href=\"https://seekingalpha.com/symbol/IAT\" title=\"iShares U.S. Regional Banks ETF\">IAT</a>, <a href=\"https://seekingalpha.com/symbol/IYG\" title=\"iShares U.S. Financial Services ETF\">IYG</a>, <a href=\"https://seekingalpha.com/symbol/FNCL\" title=\"Fidelity MSCI Financials Index ETF\">FNCL</a>, <a href=\"https://seekingalpha.com/symbol/SEF\" title=\"ProShares Short Financials ETF\">SEF</a>, <a href=\"https://seekingalpha.com/symbol/FXO\" title=\"First Trust Financials AlphaDEX ETF\">FXO</a>, <a href=\"https://seekingalpha.com/symbol/KBWB\" title=\"PowerShares KBW Bank Portfolio ETF\">KBWB</a>, <a href=\"https://seekingalpha.com/symbol/QABA\" title=\"First Trust Nasdaq ABA Community Bank ETF\">QABA</a>, <a href=\"https://seekingalpha.com/symbol/KBWR\" title=\"PowerShares KBW Regional Banking Portfolio ETF\">KBWR</a>, <a href=\"https://seekingalpha.com/symbol/RYF\" title=\"Guggenheim S&amp;P Equal Weight Financial ETF\">RYF</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227068\" data-linked=\"Bank insiders cash in amid post-election rally\" data-tweet=\"$KBE $KRE $XLF - Bank insiders cash in amid post-election rally https://seekingalpha.com/news/3227068-bank-insiders-cash-in-amid-post-election-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3227068-bank-insiders-cash-in-amid-post-election-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227060\" data-ts=\"1480346486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227060-dakota-access-protesters-say-staying-despite-order-to-leave-dec-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dakota Access protesters say they&#39;re staying despite order to leave by Dec. 5</a></h4><ul>     <li>Dakota Access pipeline protesters say they <a href=\"http://www.cnbc.com/2016/11/27/standing-rock-pipeline-protesters-vow-to-stay-camped-on-federal-land.html\" target=\"_blank\">will not leave</a> the area where hundreds have camped for months, despite a U.S. Army Corps of Engineers directive that all federal lands north of the Cannonball River will be closed to public access Dec. 5 for \"safety concerns.\"</li>     <li>Several hundred protestors on Corps land in southern North Dakota have erected semi-permanent structures or brought motor homes and trailers in advance of the harsh winter; the Corps has said it would not evict the encampment, and Standing Rock Sioux tribal leader Dave Archambault says he does not believe the Corps would forcibly evict anyone.</li>\n<li>It's the federal government's job to peacefully close the camp because  it allowed people to stay there in the first place, North Dakota Gov. Dalrymple says.</li>\n<li>Relevant tickers include ETP <font color=\"red\">-2.3%</font>, ETE <font color=\"red\">-2.6%</font>, <a href=\"https://seekingalpha.com/symbol/SXL\" title=\"Sunoco Logistics Partners, L.P.\">SXL</a> <font color=\"red\">-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227060\" data-linked=\"Dakota Access protesters say they&#39;re staying despite order to leave by Dec. 5\" data-tweet=\"$ET $ET $SXL - Dakota Access protesters say they&#39;re staying despite order to leave by Dec. 5 https://seekingalpha.com/news/3227060-dakota-access-protesters-say-staying-despite-order-to-leave-dec-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3227060-dakota-access-protesters-say-staying-despite-order-to-leave-dec-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227054\" data-ts=\"1480345650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLD\" target=\"_blank\">PLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227054-bairds-dave-rodgers-upgrades-trio-of-reits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird&#39;s Dave Rodgers upgrades trio of REITs</a></h4><ul>\n<li>Lifted to Outperform from Neutral are Prologis (<a href=\"https://seekingalpha.com/symbol/PLD\" title=\"Prologis\">PLD</a> <font color=\"green\">+1.7%</font>), Duke Realty (<a href=\"https://seekingalpha.com/symbol/DRE\" title=\"Duke Realty Corp.\">DRE</a> <font color=\"green\">+1.5%</font>), and DuPont Fabros (<a href=\"https://seekingalpha.com/symbol/DFT\" title=\"DuPont Fabros Technology\">DFT</a> <font color=\"green\">+1.5%</font>).</li>\n<li>PLD's $55 price target suggests <font color=\"green\">10% upside</font>, DRE's $30 PT <font color=\"green\">20% upside</font>, and DFT's $44 <font color=\"green\">6% upside</font>.</li>\n<li>Source: Bloomberg</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227054\" data-linked=\"Baird&#39;s Dave Rodgers upgrades trio of REITs\" data-tweet=\"$PLD $PLD $DRE - Baird&#39;s Dave Rodgers upgrades trio of REITs https://seekingalpha.com/news/3227054-bairds-dave-rodgers-upgrades-trio-of-reits?source=tweet\" data-url=\"https://seekingalpha.com/news/3227054-bairds-dave-rodgers-upgrades-trio-of-reits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227053\" data-ts=\"1480345620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227053-kandi-technologies-perks-up-after-ceo-adds-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi Technologies perks up after CEO adds shares</a></h4><ul> <li>Shares of Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) are <font color='green'>up 5.54%</font> to $4.96 in early trading.</li> <li>The company reported that CEO Hu Xiaoming snapped up 126.72K shares in two transactions last week.</li> <li><a href=\"https://www.sec.gov/Archives/edgar/data/1316517/000106299316012484/xslF345X03/form4.xml\" target=\"_blank\">SEC Form 4</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3227053\" data-linked=\"Kandi Technologies perks up after CEO adds shares\" data-tweet=\"$KNDI - Kandi Technologies perks up after CEO adds shares https://seekingalpha.com/news/3227053-kandi-technologies-perks-up-after-ceo-adds-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3227053-kandi-technologies-perks-up-after-ceo-adds-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227045\" data-ts=\"1480343896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227045-conocophillips-upgraded-to-buy-added-to-conviction-list-goldman-sachs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips upgraded to Buy, added to Conviction List, at Goldman Sachs</a></h4><ul>     <li>ConocoPhillips (<a href=\"https://seekingalpha.com/symbol/COP\" title=\"ConocoPhillips\">COP</a> <font color=\"green\">+1.6%</font>) opens higher, outpacing other big energy names, as Goldman Sachs adds the stock to its Conviction List, <a href=\"https://goo.gl/Yp8ziw\" target=\"_blank\">upgrading its rating to Buy</a> from Neutral with a $54 price target on valuation.</li>     <li>Goldman says COP offers the most attractive free cash flow yield among large cap U.S. oil majors and E&amp;Ps, as it expects capex to stay low and 2017-20 oil prices to normalize to above $50/bbl WTI, and it sees a solid capital allocation story, with COP growing the dividend, reducing its share count and paying down debt, partly through asset sale proceeds.</li>     <li>COP underperformed in 2016, largely on the back of its 66% dividend cut, but the firm expects capital returns to grow again in 2017-18, with 5%-10% annual dividend growth and a $1B/year buyback.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3227045\" data-linked=\"ConocoPhillips upgraded to Buy, added to Conviction List, at Goldman Sachs\" data-tweet=\"$COP - ConocoPhillips upgraded to Buy, added to Conviction List, at Goldman Sachs https://seekingalpha.com/news/3227045-conocophillips-upgraded-to-buy-added-to-conviction-list-goldman-sachs?source=tweet\" data-url=\"https://seekingalpha.com/news/3227045-conocophillips-upgraded-to-buy-added-to-conviction-list-goldman-sachs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227041\" data-ts=\"1480343786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTXI\" target=\"_blank\">GTXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227041-gtxs-enobosarm-successful-in-mid-stage-breast-cancer-study-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GTX&#39;s enobosarm successful in mid-stage breast cancer study; shares up 4%</a></h4><ul>\n<li>GTx (<a href=\"https://seekingalpha.com/symbol/GTXI\" title=\"GTx, Inc.\">GTXI</a>) jumps out the blocks in response to its announcement that enobosarm has achieved both stage 1 and stage 2 primary endpoints its its ongoing Phase 2 clinical trial in women with advanced estrogen receptor-positive (ER+), androgen receptor-positive (AR+) breast cancer. The company will release top-line data next month with complete results to follow in mid-2017.</li>\n<li>\n<a href=\"http://www.gtxinc.com/Pipeline/OstarineMK2866.aspx?Sid=4\" target=\"_blank\">Enobosarm</a> is a non-steroidal androgen receptor agonist. It may offer an alternative hormonal approach for the treatment of endocrine-sensitive advanced breast cancer prior to chemotherapy.</li>\n<li>Shares are up <font color=\"green\">4%</font> on increased volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3224981-stage-1-milestone-met-gtxs-mid-stage-study-lead-product-candidate-certain-type-breast-cancer\" target=\"_blank\">Stage 1 milestone met in GTx's mid-stage study of lead product candidate in certain type of breast cancer, trial to advance to Stage 2</a> (Nov. 16)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227041\" data-linked=\"GTX&#39;s enobosarm successful in mid-stage breast cancer study; shares up 4%\" data-tweet=\"$GTXI $ONCT - GTX&#39;s enobosarm successful in mid-stage breast cancer study; shares up 4% https://seekingalpha.com/news/3227041-gtxs-enobosarm-successful-in-mid-stage-breast-cancer-study-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3227041-gtxs-enobosarm-successful-in-mid-stage-breast-cancer-study-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227043\" data-ts=\"1480343486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227043-fang-holdings-opens-9-lower-q3-outlook-challenged\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings opens 9% lower; Q3, outlook challenged</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3226946-soufun-holdings-misses-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $250.13M (+0.7% Y/Y, $46.33M below estimates), EPS -$0.15, net loss $14.2M, adjusted EBITDA $1.6M (vs. $24.3M Y/Y)</li>\n<li>\n<strong>Share repurchase</strong> \u2013 17M ADSs ($81M) purchased as of November 28, to continue at a value of up to $200M.</li>\n<li>\n<strong>FY 2016 projections</strong> \u2013 revenue $927.7M (+5% Y/Y, <a href=\"https://finance.yahoo.com/quote/SFUN/analysts?p=SFUN\" target=\"_blank\">consensus $1.13B</a>) [prior forecast $1.149B]</li>\n<li>Fang Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a>) chairman and CEO Vincent Mo: \"This quarter was one of the toughest quarters in Fang's history. Our transformation coupled with the market regulations by the government was very challenging. Transformation is not easy but we are determined and optimizing the operations details. The Company achieved operational profitability and we are confident to turn around the Company.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/SFUN/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/3bj7tw96/lan/en\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227043\" data-linked=\"Fang Holdings opens 9% lower; Q3, outlook challenged\" data-tweet=\"$SFUN - Fang Holdings opens 9% lower; Q3, outlook challenged https://seekingalpha.com/news/3227043-fang-holdings-opens-9-lower-q3-outlook-challenged?source=tweet\" data-url=\"https://seekingalpha.com/news/3227043-fang-holdings-opens-9-lower-q3-outlook-challenged\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227032\" data-ts=\"1480342722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227032-h-and-r-block-lower-btig-downgrades-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;R Block lower as BTIG downgrades to Sell</a></h4><ul>\n<li>\n<a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=ficak-b\" target=\"_blank\">Analyst Mark Palmer says </a>the <font color=\"green\">9% post-election rally </font>in H&amp;R Block (NYSE:<a href=\"https://seekingalpha.com/symbol/HRB\" title=\"H&amp;R Block Inc.\">HRB</a>) reflects a complacency from investors who may be forgetting Trump's August 2015 promise to put the company out of business by simplifying the tax filing process.</li>\n<li>Even if one acknowledges this as being little more than campaign trail rhetoric, says Palmer, given Republican control of Congress to go along with President Trump, it's not out the realm to believe at least some tax simplification is coming.</li>\n<li>He also notes leading voices on the Left - Senators Sanders and Warren - this year put forth a \"Tax Simplification\" act.</li>\n<li>Palmer's $18 price target is based on 9.5x expected 2018 EPS of $1.88.</li>\n<li>Shares are <font color=\"red\">down 2.6%</font> premarket to $23.35.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227032\" data-linked=\"H&amp;R Block lower as BTIG downgrades to Sell\" data-tweet=\"$HRB - H&amp;R Block lower as BTIG downgrades to Sell https://seekingalpha.com/news/3227032-h-and-r-block-lower-btig-downgrades-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3227032-h-and-r-block-lower-btig-downgrades-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227026\" data-ts=\"1480341821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227026-needham-company-moves-to-strong-buy-on-finisarplus-3-pre-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham &amp; Company moves to Strong Buy on Finisar; +3% pre-market</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upgrades+Finisar+%28FNSR%29+to+Strong+Buy%3B+Expect+a+Beat+and+Raise/12285440.html\" target=\"_blank\">Adjusts</a> price target from $38 to $42 (current price $33.74).</li>\n<li>Analyst Alex Henderson predicts beat-and-raise quarterly results for Finisar's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a>) upcoming December 8 reporting, citing strong demand across 10G/40G and ramping of 100G products.</li>\n<li>Previously (October 31): <a href=\"https://seekingalpha.com/news/3218655-needham-and-company-remains-firmly-positive-optical-sector\" target=\"_blank\">Needham &amp; Company remains firmly positive on optical sector</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227026\" data-linked=\"Needham &amp; Company moves to Strong Buy on Finisar; +3% pre-market\" data-tweet=\"$FNSR - Needham &amp; Company moves to Strong Buy on Finisar; +3% pre-market https://seekingalpha.com/news/3227026-needham-company-moves-to-strong-buy-on-finisarplus-3-pre-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3227026-needham-company-moves-to-strong-buy-on-finisarplus-3-pre-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227025\" data-ts=\"1480341742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227025-idera-out-licenses-imominus-9200-for-up-to-155m-shares-ahead-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idera out-licenses IMO-9200 for up to $155M; shares ahead 14% premarket</a></h4><ul>\n<li>Micro cap Idera Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IDRA\" title=\"Idera Pharmaceuticals, Inc.\">IDRA</a>) is up <font color=\"green\">14%</font> premarket on robust volume in response to its announcement that it has granted a global license to <a href=\"http://vivelix.com/\" target=\"_blank\">Vivelix Pharmaceuticals, Ltd.</a> to develop and market IMO-9200 for non-malignant gastrointestinal (GI) disorders. Idera has also agreed to create and characterize potential back-up compounds for Vivelix.</li>\n<li>Under the terms of the agreement, Idera will receive $15M upfront, up to $140M in milestones and escalating royalties from mid-single-digit to low double-digits. Idera will also be eligible for up to $52.5M in milestones and the same royalty structure for the back-up compounds.</li>\n<li>\n<a href=\"http://www.iderapharma.com/pipeline-programs/\" target=\"_blank\">IMO-9200</a> is an orally available synthetic oligonucleotide-based antagonist of toll-like receptor 7,8 and 9. In preclinical studies, it demonstrated activity in disorders characterized by acute and chronic inflammation in the GI tract.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227025\" data-linked=\"Idera out-licenses IMO-9200 for up to $155M; shares ahead 14% premarket\" data-tweet=\"$IDRA - Idera out-licenses IMO-9200 for up to $155M; shares ahead 14% premarket https://seekingalpha.com/news/3227025-idera-out-licenses-imominus-9200-for-up-to-155m-shares-ahead-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3227025-idera-out-licenses-imominus-9200-for-up-to-155m-shares-ahead-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227022\" data-ts=\"1480341500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUP\" target=\"_blank\">TUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227022-tupperware-downgraded-ahead-of-f-x-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tupperware downgraded ahead of F/X update</a></h4><ul> <li>B. Riley turns negative on Tuppware Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/TUP\" title=\"Tupperware Brands Corporation\">TUP</a>) on concerns over the impact of F/X on 2017 guidance. Analyst Linda Bolton Weiser <a href=\"https://twitter.com/usratings/status/803231341433253888\" target=\"_blank\">rates</a> TUP at Sell and assigns a price target of $47 ($64 prior).</li> <li>Tupperware is due to update on F/X expectations tomorrow.</li> <li>Shares of Tupperware are <font color=\"red\">down 2.99%</font> to $57.51. in premarket action.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3227022\" data-linked=\"Tupperware downgraded ahead of F/X update\" data-tweet=\"$TUP - Tupperware downgraded ahead of F/X update https://seekingalpha.com/news/3227022-tupperware-downgraded-ahead-of-f-x-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3227022-tupperware-downgraded-ahead-of-f-x-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227018\" data-ts=\"1480341147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSH\" target=\"_blank\">CTSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227018-cognizant-technology-solutionsplus-8_7-pre-market-elliot-management-outlines-enhancement-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognizant Technology Solutions +8.7% pre-market, Elliot Management outlines enhancement plan in letter to board</a></h4><ul>\n<li>Elliot Management retains more than 4% (approximately $1.4B market value) ownership of Cognizant Technology Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTSH\" title=\"Cognizant Technology Solutions Corporation\">CTSH</a>).</li>\n<li>Notes underperformance across various segments in spite of lead positioning and suggests potential for $80-$90 per share price level (current $57.90) by year-end 2017.</li>\n<li>Full letter</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227018\" data-linked=\"Cognizant Technology Solutions +8.7% pre-market, Elliot Management outlines enhancement plan in letter to board\" data-tweet=\"$CTSH - Cognizant Technology Solutions +8.7% pre-market, Elliot Management outlines enhancement plan in letter to board https://seekingalpha.com/news/3227018-cognizant-technology-solutionsplus-8_7-pre-market-elliot-management-outlines-enhancement-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3227018-cognizant-technology-solutionsplus-8_7-pre-market-elliot-management-outlines-enhancement-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3227013\" data-ts=\"1480340666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTZ\" target=\"_blank\">MTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3227013-cuba-fund-soars-after-fidels-death\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Cuba&quot; fund soars after Fidel&#39;s death</a></h4><ul>\n<li>The Herzfeld Caribbean Basin Fund (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CUBA\" title=\"Herzfeld Caribbean Basin Fund\">CUBA</a>) is <font color=\"green\">higher by 16.3%</font> in premarket action after the dictator's passing over the weekend. Premarket volume of about 167K shares is already six times the normal full-day average.</li>\n<li>For now, <a href=\"http://www.marketwatch.com/story/cuba-ticker-fund-soars-after-fidel-castros-passing-2016-11-28\" target=\"_blank\">the fund invests in companies</a> likely to benefit from a more open Cuban economy.</li>\n<li>Among the holdings: Mastec (NYSE:<a href=\"https://seekingalpha.com/symbol/MTZ\" title=\"MasTec, Inc.\">MTZ</a>), Royal Caribbean (NYSE:<a href=\"https://seekingalpha.com/symbol/RCL\" title=\"Royal Caribbean Cruises Ltd.\">RCL</a>), Carnival Corp. (NYSE:<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a>), Nextera Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/NEE\" title=\"NextEra Energy, Inc.\">NEE</a>), Norwegian Cruise (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NCLH\" title=\"Norwegian Cruise Line Holdings Ltd.\">NCLH</a>), Copa Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/CPA\" title=\"Copa Holdings, S.A.\">CPA</a>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3227013\" data-linked=\"&quot;Cuba&quot; fund soars after Fidel&#39;s death\" data-tweet=\"$MTZ $CUBA $MTZ - &quot;Cuba&quot; fund soars after Fidel&#39;s death https://seekingalpha.com/news/3227013-cuba-fund-soars-after-fidels-death?source=tweet\" data-url=\"https://seekingalpha.com/news/3227013-cuba-fund-soars-after-fidels-death\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226994\" data-ts=\"1480338183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNRA\" target=\"_blank\">PNRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226994-wedbush-lowers-expectations-on-panera-bread\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush lowers expectations on Panera Bread</a></h4><ul> <li>Wedbush <a href=\"http://www.cnbc.com/2016/11/28/early-movers-amzn-m-wmt-tgt-jwn-ba-mrk-dis-wfc-t-more.html\" target=\"_blank\">lowers</a> its rating on Panera Bread (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PNRA\" title=\"Panera Bread Company\">PNRA</a>) to Neutral from Outperform.</li> <li>The investment firm keeps its price target on the restaurant stock set at $220.</li> <li>Shares of Panera are <font color=\"red\">down 1.06%</font> premarket to $214.85 vs. a 52-week trading range of $178.99 to $224.15.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226994\" data-linked=\"Wedbush lowers expectations on Panera Bread\" data-tweet=\"$PNRA - Wedbush lowers expectations on Panera Bread https://seekingalpha.com/news/3226994-wedbush-lowers-expectations-on-panera-bread?source=tweet\" data-url=\"https://seekingalpha.com/news/3226994-wedbush-lowers-expectations-on-panera-bread\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226990\" data-ts=\"1480337870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226990-time-inc-reportedly-turns-down-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time Inc. reportedly turns down buyout offer</a></h4><ul> <li>The board at Time Inc. (TIME) decided to <a href=\"http://nypost.com/2016/11/28/time-inc-board-reportedly-rejects-investors-bid/\" target=\"_blank\">turn down</a> an offer from Edgar Bronfman to buy the company for $18 per share, reports New York Post.</li> <li>Bronfman teamed up with Access Industries and Israeli businessman Ynon Kreiz on the buyout bid.</li> <li>Shares of Time are <font color=\"green\">up 5.07%</font> to $14.50 in premarket action.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3226990\" data-linked=\"Time Inc. reportedly turns down buyout offer\" data-tweet=\"$MDP - Time Inc. reportedly turns down buyout offer https://seekingalpha.com/news/3226990-time-inc-reportedly-turns-down-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3226990-time-inc-reportedly-turns-down-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226988\" data-ts=\"1480337626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226988-barclays-sells-asia-wealth-management-ops-for-just-225m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays sells Asia wealth management ops for just $225M</a></h4><ul>\n<li>A few months back, Barclays (NYSE:<a href=\"https://seekingalpha.com/symbol/BCS\" title=\"Barclays PLC\">BCS</a>) had hoped to raise $320M from the sale of its wealth- and investment-management business in Singapore and Hong Kong, <a href=\"https://www.ft.com/content/a97f6164-b55f-11e6-ba85-95d1533d9a62\" target=\"_blank\">but the final price was just $225M</a> (at the end of 2015, it had been valued at $500M).</li>\n<li>The buyer was Singapore's Oversea-Chinese Banking Corp.</li>\n<li>The lower price was thanks to some clients deciding to move their assets to another bank as the price of the deal was fixed at 1.75% of AUM.</li>\n<li>The deal will reduce risk-weighted assets at Barclays by about £800M, a part of the bank's plan to cut RWA to £23B next year.</li>\n<li>Shares are<font color=\"red\"> lower by 1.8%</font>, inline with a broad move down in European banks today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226988\" data-linked=\"Barclays sells Asia wealth management ops for just $225M\" data-tweet=\"$BCS - Barclays sells Asia wealth management ops for just $225M https://seekingalpha.com/news/3226988-barclays-sells-asia-wealth-management-ops-for-just-225m?source=tweet\" data-url=\"https://seekingalpha.com/news/3226988-barclays-sells-asia-wealth-management-ops-for-just-225m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226985\" data-ts=\"1480337323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPH\" target=\"_blank\">REPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226985-recro-pharmas-iv-meloxicam-successful-in-late-stage-study-nda-filing-on-tap-for-next-summer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recro Pharma&#39;s IV meloxicam successful in late-stage study; NDA filing on tap for next summer; shares up 20% premarket</a></h4><ul>\n<li>A Phase 3 clinical trial assessing Recro Pharma's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/REPH\" title=\"Recro Pharma Inc\">REPH</a>) IV meloxicam for the treatment of serious acute pain <a href=\"https://www.sec.gov/Archives/edgar/data/1588972/000119312516777415/d288858dex991.htm\" target=\"_blank\">met its primary endpoint</a> of a statistically valid difference in pain relief compared to placebo in patients following abdominoplasty surgery.</li>\n<li>Study participants (n=219) were randomized 1:1 to receive either IV meloxicam or placebo once every 24 hours following surgery. The IV meloxicam cohort showed a statistically significant reduction in pain intensity as measured by a scale called SPID24 versus placebo (p=0.0145). The trial also achieved 10 secondary endpoints.</li>\n<li>IV meloxicam was well-tolerated with no difference in the incidence of serious adverse events related to bleeding compared to placebo (one each). The most common adverse events in the IV meloxicam group were nausea, headache, vomiting and dizziness. All occurred less frequently than the placebo cohort. The majority were mild in nature.</li>\n<li>The company intends to submit the data for presentation at a future scientific conference or for publication. It expects to file a New Drug Application (NDA) in the U.S. next summer.</li>\n<li>Shares are up <font color=\"green\">20%</font> premarket on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226985\" data-linked=\"Recro Pharma&#39;s IV meloxicam successful in late-stage study; NDA filing on tap for next summer; shares up 20% premarket\" data-tweet=\"$REPH - Recro Pharma&#39;s IV meloxicam successful in late-stage study; NDA filing on tap for next summer; shares up 20% premarket https://seekingalpha.com/news/3226985-recro-pharmas-iv-meloxicam-successful-in-late-stage-study-nda-filing-on-tap-for-next-summer?source=tweet\" data-url=\"https://seekingalpha.com/news/3226985-recro-pharmas-iv-meloxicam-successful-in-late-stage-study-nda-filing-on-tap-for-next-summer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226970\" data-ts=\"1480336060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226970-qualcomm-lower-baml-cashes-in-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm lower as BAML cashes in some chips</a></h4><ul>\n<li>The team at Bank of America pulls Qualcomm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QCOM\" title=\"Qualcomm Inc.\">QCOM</a>) from its U.S. 1 List following the stock's big run -<font color=\"green\"> up 37%</font> for the year.</li>\n<li>Shares are <font color=\"red\">down 0.8%</font> in very thin premarket action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226970\" data-linked=\"Qualcomm lower as BAML cashes in some chips\" data-tweet=\"$QCOM - Qualcomm lower as BAML cashes in some chips https://seekingalpha.com/news/3226970-qualcomm-lower-baml-cashes-in-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3226970-qualcomm-lower-baml-cashes-in-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3226960\" data-ts=\"1480335362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3226960-stocks-set-for-lower-open-gold-catches-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks set for lower open; gold catches bid</a></h4><ul>\n<li>A bit of political instability could be shaking markets this morning as the Clinton campaign <a href=\"https://seekingalpha.com/news/3226915-clinton-take-part-recounts\" target=\"_blank\">has resurfaced</a> in the U.S. to throw its weight behind recount efforts in three states, and investors look ahead to a key referendum in Italy next weekend.</li>\n<li>U.S. stock index futures are <font color=\"red\">down 0.35%</font> across the board, and Italy's (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/EWI\" title=\"iShares MSCI Italy Capped ETF\">EWI</a>) <font color=\"red\">1.4% decline</font> is leading Europe lower.</li>\n<li>If voters on Sunday <a href=\"https://www.bloomberg.com/news/articles/2016-11-27/dollar-pulls-back-amid-yen-gains-as-asian-index-futures-diverge\" target=\"_blank\">reject Italian Prime Minister Renzi's</a> constitutional reform, he's likely gone, and up to eight Italian banks are at risk of failing.</li>\n<li>The 10-year U.S. Treasury yield is lower by 1.8 basis points to 2.335%, and gold's <font color=\"green\">up 1% </font>to $1,193 per ounce. Oil is <font color=\"red\">down 0.6%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/SH\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/SSO\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/VOO\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/SDS\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/IVV\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/SPXU\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/TQQQ\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/PSQ\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXL\" title=\"Direxion Daily S&amp;P 500 Bull 3x Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/RSP\" title=\"Guggenheim S&amp;P 500 Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/SPXS\" title=\"Direxion Daily S&amp;P 500 Bear 3x Shares ETF\">SPXS</a>, <a href=\"https://seekingalpha.com/symbol/SQQQ\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/QID\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/DOG\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/QLD\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/DXD\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/UDOW\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/RWL\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/SDOW\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/VFINX\" title=\"Vanguard 500 Index Fund Inv\">VFINX</a>, <a href=\"https://seekingalpha.com/symbol/EPS\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/DDM\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/QQEW\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/BXUB\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/QQQE\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/SPLX\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/SFLA\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/BXUC\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/QQXT\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/SPUU\" title=\"Direxion Daily S&amp;P 500 Bull 2x Shares ETF\">SPUU</a>, <a href=\"https://seekingalpha.com/symbol/SPXE\" title=\"ProShares S&amp;P 500 Ex-Energy ETF\">SPXE</a>, <a href=\"https://seekingalpha.com/symbol/LLSP\" title=\"Direxion Daily S&amp;P 500 Bull 1.25X Shares\">LLSP</a>, <a href=\"https://seekingalpha.com/symbol/UDPIX\" title=\"ProFunds Ultra Dow 30 ProFund Inv\">UDPIX</a>, <a href=\"https://seekingalpha.com/symbol/OTPIX\" title=\"ProFunds NASDAQ-100 Fund Inv\">OTPIX</a>, <a href=\"https://seekingalpha.com/symbol/RYARX\" title=\"Rydex Inverse S&amp;P 500® Strategy Fund A\">RYARX</a>, <a href=\"https://seekingalpha.com/symbol/SPXN\" title=\"ProShares S&amp;P 500 Ex-Financial ETF\">SPXN</a>, <a href=\"https://seekingalpha.com/symbol/SPDN\" title=\"Direxion Daily S&amp;P 500 Bear 1x Shares ETF\">SPDN</a>, <a href=\"https://seekingalpha.com/symbol/SPXT\" title=\"ProShares S&amp;P 500 Ex-Technology ETF\">SPXT</a>, <a href=\"https://seekingalpha.com/symbol/SPXV\" title=\"ProShares S&amp;P 500 Ex-Health Care ETF\">SPXV</a>, <a href=\"https://seekingalpha.com/symbol/TALL\" title=\"RBC S&amp;P 500 Trend Allocator Index ETN\">TALL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3226960\" data-linked=\"Stocks set for lower open; gold catches bid\" data-tweet=\"$EWI $SPY $QQQ - Stocks set for lower open; gold catches bid https://seekingalpha.com/news/3226960-stocks-set-for-lower-open-gold-catches-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3226960-stocks-set-for-lower-open-gold-catches-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":57,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}